169 related articles for article (PubMed ID: 22609113)
1. Novel metal-based anticancer drugs: a new challenge in drug delivery.
Lainé AL; Passirani C
Curr Opin Pharmacol; 2012 Aug; 12(4):420-6. PubMed ID: 22609113
[TBL] [Abstract][Full Text] [Related]
2. Drug Delivery Systems For Anti-Cancer Active Complexes of Some Coinage Metals.
Zhang M; Saint-Germain C; He G; Sun RW
Curr Med Chem; 2018 Feb; 25(4):493-505. PubMed ID: 28545356
[TBL] [Abstract][Full Text] [Related]
3. Metal-based anticancer chemotherapeutic agents.
Muhammad N; Guo Z
Curr Opin Chem Biol; 2014 Apr; 19():144-53. PubMed ID: 24608084
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs.
Sava G; Jaouen G; Hillard EA; Bergamo A
Dalton Trans; 2012 Jul; 41(27):8226-34. PubMed ID: 22614531
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of anticancer drugs: challenges and opportunities.
Thanki K; Gangwal RP; Sangamwar AT; Jain S
J Control Release; 2013 Aug; 170(1):15-40. PubMed ID: 23648832
[TBL] [Abstract][Full Text] [Related]
7. Chemical approaches to the discovery and development of cancer therapies.
Neidle S; Thurston DE
Nat Rev Cancer; 2005 Apr; 5(4):285-96. PubMed ID: 15803155
[TBL] [Abstract][Full Text] [Related]
8. Metal based drugs: from serendipity to design.
Fricker SP
Dalton Trans; 2007 Nov; (43):4903-17. PubMed ID: 17992275
[TBL] [Abstract][Full Text] [Related]
9. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
Tan SJ; Yan YK; Lee PP; Lim KH
Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
[TBL] [Abstract][Full Text] [Related]
10. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
Zhang E; Zhang C; Su Y; Cheng T; Shi C
Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
[TBL] [Abstract][Full Text] [Related]
11. Metallodrugs in Targeted Cancer Therapeutics: Aiming at Chemoresistance- related Patterns and Immunosuppressive Tumor Networks.
Petanidis S; Kioseoglou E; Salifoglou A
Curr Med Chem; 2019; 26(4):607-623. PubMed ID: 29149832
[TBL] [Abstract][Full Text] [Related]
12. Dendrimers and dendritic polymers in drug delivery.
Gillies ER; Fréchet JM
Drug Discov Today; 2005 Jan; 10(1):35-43. PubMed ID: 15676297
[TBL] [Abstract][Full Text] [Related]
13. Polymeric micelles drug delivery system in oncology.
Gong J; Chen M; Zheng Y; Wang S; Wang Y
J Control Release; 2012 May; 159(3):312-23. PubMed ID: 22285551
[TBL] [Abstract][Full Text] [Related]
14. From metallodrugs to metallodendrimers for nanotherapy in oncology: a concise overview.
El Kazzouli S; El Brahmi N; Mignani S; Bousmina M; Zablocka M; Majoral JP
Curr Med Chem; 2012; 19(29):4995-5010. PubMed ID: 22963626
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines.
Greco F; Vicent MJ
Adv Drug Deliv Rev; 2009 Nov; 61(13):1203-13. PubMed ID: 19699247
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of anticancer drugs I: general considerations.
Mazzaferro S; Bouchemal K; Ponchel G
Drug Discov Today; 2013 Jan; 18(1-2):25-34. PubMed ID: 22951365
[TBL] [Abstract][Full Text] [Related]
17. Thiosemicarbazones: the new wave in cancer treatment.
Kalinowski DS; Quach P; Richardson DR
Future Med Chem; 2009 Sep; 1(6):1143-51. PubMed ID: 21425997
[TBL] [Abstract][Full Text] [Related]
18. Physical mechanisms and methods employed in drug delivery to tumors.
Besić E
Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
[TBL] [Abstract][Full Text] [Related]
19. Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs.
Hartinger CG; Groessl M; Meier SM; Casini A; Dyson PJ
Chem Soc Rev; 2013 Jul; 42(14):6186-99. PubMed ID: 23660626
[TBL] [Abstract][Full Text] [Related]
20. [Target selectivity of anticancer drugs].
Fattoruso SI; Di Lauro L; Conti F; Amodio A; Lopez M
Clin Ter; 2008; 159(3):189-206. PubMed ID: 18594750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
